Clinical Trial Update: Olive Leaf Extracts in the Control of Diabet [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates Phase 2 and Phase 3 studies are recruiting to evaluate olive leaf extracts for controlling type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Olive Leaf Extract (Olea europaea leaf extract)

Snippet

Sponsor: University of Monastir | Conditions: Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: RECRUITING